Alternatives to EyePoint Pharmaceuticals

Pioneering vision restoration therapies for severe retinal degenerations.

Clinical-stage company developing novel treatments for ocular inflammatory blinding diseases.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Biotechnology company developing plant-based biomaterials for regenerative medicine and tissue engineering.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

Developing ultrasound-mediated nonviral genetic medicines.

Revolutionizing genomic analysis with innovative sequencing technology.

Developing advanced vision restoration technology through a retinal implant.

Developing a new generation of molecular diagnostics for at-home use, combining laboratory accuracy with rapid test simplicity.

Developing lightweight bionic technology.

NeuroTech company developing therapies to restore movement and independence for people with spinal cord injuries.

Developing a novel therapeutic approach for Alzheimer's disease.

Developing non-invasive ultrasound neuromodulation therapies for chronic immune-mediated diseases and inflammatory disorders.

Clinical-stage pharmaceutical company developing innovative oral therapies for diabetes and metabolic disorders.

Developing soft, stretchable brain-computer interface platforms.

Developing novel male contraceptives.

Develops and distributes bioreactor technology for stem cell cultivation.

Developing a new histotripsy therapeutic platform for cancer treatment.

Developing innovative gene therapies to preserve or restore vision in patients with retinal diseases.

AI-driven biotechnology company developing novel protein therapeutics through generative biology.

Elevating uterine health through innovative biomaterial therapies.

Develops multimodal hemoadsorption therapeutic devices for sepsis and septic shock.

Developing a next-generation, off-the-shelf, in vivo engineered monocyte immunotherapy platform for solid tumors.

Biotech company developing novel drug delivery technologies.

Optimizing the delivery and efficacy of cancer therapeutics through hyperthermic intravesical chemotherapy.

Developing breath-based diagnostics for lung diseases.

A clinical-stage dermatology company developing novel therapies for inflammatory skin diseases.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Pioneering intracoronary liquid biopsy to identify inflammatory drivers of cardiovascular disease.

AI safety and research company building reliable, interpretable, and steerable AI systems.

Developing innovative ophthalmic devices for refractive surgery, specifically the Gemini Refractive Capsule for cataract surgery.

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

Biotechnology company developing and commercializing cell therapies for cancer treatment.

Developing medical-grade smart contact lenses for continuous health monitoring.

Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Developing novel therapeutics to restore gut lymphatic function.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Clinical-stage biotechnology company developing autologous neuron replacement medicines for neurodegenerative disorders.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

Global supplier of life science research tools, including antibodies, reagents, and assays.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Leveraging AI and a massive patient tissue dataset to accelerate drug discovery and advance precision medicine.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Enzyme-based technology to break down alcohol in the stomach.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

A vertically-integrated procurement platform for the life sciences industry.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Biopharmaceutical company developing and commercializing CNS disease treatments.

A global leader in clinical pharmacology and bioanalytical sciences.

Global biopharmaceutical company developing breakthrough treatments for ophthalmic and neuro-ophthalmic conditions.

A leading organization dedicated to curing and treating cystic fibrosis.